Differences in Tacrolimus Troughs and Doses Between Caucasians and African Americans with Two CYP3A5 Loss-of-Function Alleles: Looking Beyond CYP3A5 Expression.

被引：0
|
作者：
Oetting, W. [1 ]
Schladt, D. [2 ,3 ]
Guan, W. [1 ]
Remmel, R. [1 ]
Dorr, C. [2 ,3 ]
Sanghavi, K. [1 ]
Matas, A. [1 ]
Mannon, R. [4 ]
Israni, A. [2 ,3 ]
Jacobson, P. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN USA
[3] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C251
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [31] Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3
    Ito, Ayano
    Okada, Yuko
    Hashita, Tadahiro
    Aomori, Tohru
    Hiromura, Keiju
    Nojima, Yoshihisa
    Nakamura, Tomonori
    Araki, Takuya
    Yamamoto, Koujirou
    BIOCHEMICAL GENETICS, 2017, 55 (03) : 268 - 277
  • [32] THE IMPACT OF CYP3A5 GENOTYPE ON TACROLIMUS TROUGH CONCENTRATIONS VARIES BETWEEN ROUTES OF ADMINISTRATION.
    Pasternak, A. L.
    Kidwell, K.
    Dempsey, J.
    Sun, Y.
    Hertz, D. L.
    Park, J. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S46 - S47
  • [33] Target Tacrolimus Troughs and CYP3A5 Polymorphisms Do Not Predict Therapeutic Drug Exposure in African American and Caucasian Renal Transplant Recipients.
    Tornatore, K.
    Attwood, K.
    Brazeau, D.
    Chang, S.
    Venuto, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 804 - 804
  • [34] Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3
    Ayano Ito
    Yuko Okada
    Tadahiro Hashita
    Tohru Aomori
    Keiju Hiromura
    Yoshihisa Nojima
    Tomonori Nakamura
    Takuya Araki
    Koujirou Yamamoto
    Biochemical Genetics, 2017, 55 : 268 - 277
  • [35] Impact of donor CYP3A5 genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients
    Wheeler, C.
    Masimirembwa, C.
    Mthembu, B.
    Botha, J.
    Scholefield, J.
    Fabian, J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2024, 114 (3B): : 70 - 78
  • [36] PREDICTING THE IMPACT OF CYP3A5 POLYMORPHISM ON TACROLIMUS TROUGH CONCENTRATIONS IN BLACK AFRICAN TRANSPLANT RECIPIENTS.
    Machavaram, K.
    Almond, L.
    Small, B.
    Barter, Z.
    Jamei, M.
    Rostami-Hodjegan, A.
    Gardner, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S99 - S99
  • [37] CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population
    Muller, W. K.
    Dandara, C.
    Manning, K.
    Mhandire, D.
    Ensor, J.
    Barday, Z.
    Freercks, R.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (02): : 159 - 166
  • [38] Study on the regularity between CYP3A5/3A4 polymorphism in medication of tacrolimus after renal transplantation
    Guo, Yuan-yuan
    Jiang, Wen-tao
    Shen, Zhong-yang
    Zhang, Yi
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 37 - 37
  • [39] Influence of CYP3A5 Polymorphism on Tacrolimus Doses and Serum Level after Renal Transplantation: Pharmacological Interaction with Steroids
    Ferraris, J. R.
    Larriba, J. M.
    Torres Fuenzalida, J.
    Gimenez, G.
    Coccia, P. A.
    Ghezzi, L. F. R.
    Ferraris, V.
    Redal, M. A.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1808 - 1808
  • [40] Study on the regularity between CYP3A5/3A4 polymorphism in medication of tacrolimus after renal transplantation
    Acta Pharmacologica Sinica, 2013, 34 (Suppl 1) : S37 - S42
12345